0,901  0,006  Apoptosis agonist
0,857  0,002  NOS3 expression enhancer
0,850  0,004  Antiosteoporotic
0,833  0,002  Estrogen receptor alpha antagonist
0,835  0,004  Antioxidant
0,833  0,014  Alpha-glucosidase inhibitor
0,821  0,004  Free radical scavenger
0,815  0,003  Estrogen antagonist
0,816  0,004  Bone diseases treatment
0,754  0,002  Cystathionine beta-synthase inhibitor
0,734  0,003  Estrogen receptor beta antagonist
0,742  0,015  Antineoplastic (breast cancer)
0,738  0,019  Caspase 9 stimulant
0,713  0,004  Topoisomerase II inhibitor
0,709  0,005  Amyloid beta aggregation inhibitor
0,701  0,003  Estrogen agonist
0,699  0,011  Alzheimer's disease treatment
0,678  0,004  Skin whitener
0,680  0,006  Nitric oxide antagonist
0,699  0,031  Antiinflammatory
0,671  0,012  Prostate cancer treatment
0,643  0,025  Antineoplastic (lung cancer)
0,623  0,006  Antimutagenic
0,613  0,002  Estrogen receptor beta agonist
0,620  0,029  Transcription factor NF kappa B inhibitor
0,594  0,006  Vasodilator
0,594  0,011  Caspase 3 stimulant
0,586  0,009  UGT1A6 substrate
0,598  0,028  Antidiabetic
0,598  0,028  Cyclophilin D inhibitor
0,581  0,013  UGT1A9 substrate
0,580  0,014  Chemopreventive
0,568  0,004  Lipid peroxidase inhibitor
0,571  0,012  NOS2 expression inhibitor
0,569  0,014  Cardioprotectant
0,547  0,004  Topoisomerase I inhibitor
0,540  0,008  Antihypertriglyceridemic
0,555  0,026  Antiparkinsonian
0,525  0,003  Postmenopausal disorders treatment
0,546  0,029  Antibacterial
0,533  0,017  AR expression inhibitor
0,531  0,025  Immunosuppressant
0,505  0,007  Monophenol monooxygenase inhibitor
0,503  0,005  Amylase inhibitor
0,499  0,005  Acetylcholinesterase inhibitor
0,529  0,035  Antileukemic
0,511  0,019  Apoptosis antagonist
0,494  0,009  P-glycoprotein inhibitor
0,504  0,019  NOS3 expression inhibitor
0,501  0,028  Histamine release inhibitor
0,480  0,008  UGT1A3 substrate
0,502  0,033  Aldehyde oxidase inhibitor
0,471  0,004  SULT1A3 substrate
0,469  0,005  UGT2B15 substrate
0,473  0,013  UDP-glucuronosyltransferase substrate
0,482  0,028  CYP2C19 inhibitor
0,457  0,008  Genotoxic
0,466  0,019  Hypoglycemic
0,470  0,025  CTGF expression inhibitor
0,451  0,008  Cholinergic
0,481  0,039  Antineoplastic (colorectal cancer)
0,483  0,044  15-Lipoxygenase inhibitor
0,488  0,050  TNF expression inhibitor
0,461  0,026  Chemoprotective
0,453  0,027  Antimycobacterial
0,455  0,031  Antifungal
0,430  0,014  UGT1A1 substrate
0,443  0,030  Antineoplastic (cervical cancer)
0,444  0,032  CYP1A2 substrate
0,439  0,029  Lipoxygenase inhibitor
0,438  0,028  Cytostatic
0,413  0,004  Histone deacetylase class III inhibitor
0,432  0,032  Antineoplastic (brain cancer)
0,403  0,004  Histone deacetylase SIRT1 inhibitor
0,434  0,043  Antineoplastic (colon cancer)
0,425  0,039  Antihypercholesterolemic
0,430  0,045  Angiogenesis inhibitor
0,417  0,034  ICAM1 expression inhibitor
0,414  0,030  Antituberculosic
0,393  0,012  Melanin inhibitor
0,413  0,033  Antineoplastic (glioma)
0,389  0,014  Hepatoprotectant
0,400  0,031  UGT2B4 substrate
0,396  0,029  DNA damaging
0,373  0,017  GST M1-1 substrate
0,382  0,032  Antiamyloidogenic
0,373  0,025  Peroxidase inhibitor
0,365  0,021  5 Hydroxytryptamine uptake stimulant
0,379  0,036  Hypoxia-inducible factor 1 alpha inhibitor
0,350  0,008  Protein-tyrosine phosphatase 1B inhibitor
0,376  0,033  Proliferative diseases treatment
0,341  0,003  Estrogen receptor alpha agonist
0,397  0,063  GABA C receptor rho-3 antagonist
0,368  0,034  Mutagenic
0,337  0,004  Creatine kinase inhibitor
0,334  0,007  Antihemorrhagic
0,339  0,013  Protein-tyrosine phosphatase inhibitor
0,343  0,019  Contraceptive
0,354  0,040  Antiprotozoal (Leishmania)
0,315  0,012  Glutathione S-transferase substrate
0,312  0,013  Insulin sensitizer
0,305  0,007  Xanthine oxidase inhibitor
0,307  0,010  Sulfotransferase substrate
0,350  0,060  Hepatic disorders treatment
0,348  0,058  CYP2D6 substrate
0,335  0,047  Sensitization
0,297  0,012  Nitric-oxide synthase stimulant
0,292  0,008  Topoisomerase II alpha inhibitor
0,306  0,024  VCAM1 expression inhibitor
0,357  0,076  CYP3A4 substrate
0,313  0,043  Antineoplastic (glioblastoma multiforme)
0,318  0,048  Cytotoxic
0,294  0,028  UGT2B7 substrate
0,316  0,060  CYP2C19 substrate
0,289  0,034  Antihypotensive
0,258  0,005  Aldose reductase inhibitor
0,267  0,015  LDLR expression enhancer
0,276  0,026  Neurotrophic factor enhancer
0,330  0,082  Antiprotozoal (Plasmodium)
0,248  0,007  Dopamine agonist
0,269  0,032  Pneumotoxic
0,243  0,011  UGT2B1 substrate
0,304  0,074  Antineoplastic (small cell lung cancer)
0,276  0,051  Antimitotic
0,286  0,061  Antipyretic
0,296  0,073  Antineoplastic (osteosarcoma)
0,244  0,022  UGT2B9 substrate
0,251  0,030  Antineoplastic (squamous cell carcinoma)
0,324  0,107  Antiprotozoal
0,315  0,099  Ulceration
0,229  0,024  VEGF expression inhibitor
0,282  0,078  Antineoplastic (melanoma)
0,208  0,005  Dopamine D5 antagonist
0,273  0,071  CYP1A2 inhibitor
0,236  0,038  Antiviral (Hepatitis)
0,208  0,012  Histidine decarboxylase inhibitor
0,237  0,045  UGT1A4 substrate
0,207  0,017  SULT1A1 substrate
0,217  0,029  NADPH oxidase inhibitor
0,208  0,024  Alkylator
0,200  0,020  Endometrios treatment
0,213  0,035  Antiviral (Hepatitis C)
0,186  0,008  SULT1E1 substrate
0,298  0,122  Antipruritic, allergic
0,185  0,014  Multidrug resistance-associated protein 1 inhibitor
0,195  0,027  Gout treatment
0,176  0,018  Antineoplastic (uterine cancer)
0,220  0,062  Antiviral (Influenza)
0,177  0,020  Carbonic anhydrase III inhibitor
0,171  0,015  Prolactin inhibitor
0,245  0,091  5 Hydroxytryptamine release stimulant
0,175  0,021  Gastritis treatment
0,170  0,020  Papain-like protease (SARS coronavirus) inhibitor
0,161  0,012  Aromatase inhibitor
0,173  0,026  Antineoplastic antibiotic
0,191  0,044  MAO inhibitor
0,178  0,033  Cholesterol synthesis inhibitor
0,241  0,097  Antineoplastic (ovarian cancer)
0,160  0,016  NAD(P)H dehydrogenase (quinone) inhibitor
0,245  0,103  Antihypoxic
0,160  0,021  Beta glucuronidase inhibitor
0,164  0,026  Carbonic anhydrase XV inhibitor
0,145  0,010  Lipase inhibitor
0,223  0,092  Antineoplastic (non-small cell lung cancer)
0,232  0,101  Lipoprotein disorders treatment
0,201  0,071  Abortion inducer
0,223  0,095  Antineoplastic (sarcoma)
0,186  0,062  Succinate dehydrogenase inhibitor
0,164  0,042  DNA polymerase I inhibitor
0,160  0,038  MAO A inhibitor
0,226  0,106  Immunostimulant
0,172  0,055  Carcinogenic, group 1
0,142  0,026  DOPA decarboxylase inhibitor
0,205  0,092  RNA-directed DNA polymerase inhibitor
0,168  0,056  Protein kinase stimulant
0,232  0,121  Metabolic disease treatment
0,252  0,140  GST A substrate
0,176  0,066  Toxic, respiratory center
0,168  0,059  Interferon gamma antagonist
0,197  0,088  Antialcoholic
0,161  0,053  Tubulin antagonist
0,112  0,004  Dopamine D5 agonist
0,138  0,031  Alpha 2 adrenoreceptor antagonist
0,124  0,019  Dopamine D1 antagonist
0,245  0,140  Vasodilator, coronary
0,134  0,031  Electron transport complex I inhibitor
0,150  0,048  Cyclooxygenase 3 inhibitor
0,141  0,041  Contraceptive female
0,133  0,034  Protein kinase C mu inhibitor
0,168  0,070  Antihelmintic (Nematodes)
0,113  0,017  SULT1A2 substrate
0,100  0,006  Postcoital contraceptive
0,157  0,064  Antidiarrheal
0,253  0,160  CYP2C9 inhibitor
0,166  0,073  UGT2B10 substrate
0,112  0,020  Antiviral (Hepatitis A)
0,112  0,021  Histone deacetylase SIRT1 stimulant
0,112  0,021  Histone deacetylase stimulant
0,199  0,110  Tumour necrosis factor alpha release inhibitor
0,171  0,082  Antipruritic, non-allergic
0,147  0,059  Cyclooxygenase 1 inhibitor
0,142  0,054  Antihelmintic (Trematoda)
0,197  0,110  Antineoplastic (liver cancer)
0,089  0,003  Dopamine D1 agonist
0,105  0,020  Narcotic antagonist
0,110  0,028  Opioid kappa receptor antagonist
0,118  0,037  Opioid antagonist
0,116  0,038  UGT2B11 substrate
0,087  0,012  Transcription factor RelA inhibitor
0,099  0,024  Ca(v)3.1 blocker
0,128  0,053  Antiviral (Influenza B)
0,155  0,082  Arachidonic acid antagonist
0,102  0,029  Keratolytic
0,166  0,093  Antirickettsial
0,141  0,069  Ca2+-transporting ATPase inhibitor
0,145  0,074  Cyclooxygenase inhibitor
0,121  0,050  MAO B inhibitor
0,105  0,034  Alpha 2a adrenoreceptor antagonist
0,108  0,041  Androgen antagonist
0,088  0,021  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,069  0,003  Toll-Like receptor 4 agonist
0,102  0,038  Carbonic anhydrase VI inhibitor
0,128  0,065  M18 aspartyl aminopeptidase inhibitor
0,083  0,022  SULT2A1 substrate
0,110  0,049  Anabolic
0,098  0,037  Antiprotozoal activity enhancer
0,221  0,161  Sodium/bile acid cotransporter inhibitor
0,079  0,019  Fatty acid synthase inhibitor
0,072  0,012  Progesterone antagonist
0,182  0,123  Cardiovascular analeptic
0,228  0,170  CYP2C9 substrate
0,077  0,021  Alpha tubulin antagonist
0,108  0,051  Antiadrenergic
0,122  0,066  Beta amyloid protein antagonist
0,146  0,091  Prostatic (benign) hyperplasia treatment
0,118  0,063  Microtubule formation inhibitor
0,105  0,051  Adrenaline antagonist
0,093  0,038  Na+ K+ transporting ATPase inhibitor
0,180  0,126  Antineoplastic (renal cancer)
0,171  0,117  Hypolipemic
0,100  0,046  Carcinogenic, group 2A
0,221  0,170  Stroke treatment
0,162  0,111  CYP2B6 inhibitor
0,106  0,055  Dementia treatment
0,108  0,058  Toll-Like receptor 4 antagonist
0,139  0,090  GABA C receptor rho-2 antagonist
0,132  0,083  Antineoplastic (carcinoma)
0,149  0,100  Carcinogenic
0,102  0,055  Vascular dementia treatment
0,052  0,005  Estrogen-related receptor beta antagonist
0,063  0,019  Dopamine D2 agonist
0,056  0,013  Glucocorticoid antagonist
0,075  0,034  Glutamate (mGluR7) antagonist
0,073  0,032  Adrenaline uptake inhibitor
0,060  0,020  Squalene epoxidase inhibitor
0,095  0,057  Protein kinase C zeta inhibitor
0,070  0,031  Xanthine dehydrogenase inhibitor
0,161  0,123  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,106  0,069  GABA C receptor antagonist
0,063  0,027  Opioid agonist
0,132  0,097  Adenylate cyclase stimulant
0,058  0,024  Topoisomerase II beta inhibitor
0,099  0,065  5-Lipoxygenase inhibitor
0,136  0,103  CF transmembrane conductance regulator agonist
0,068  0,035  Neuraminidase inhibitor
0,089  0,057  Ornithine decarboxylase inhibitor
0,104  0,072  Mucolytic
0,146  0,114  Antihelmintic
0,053  0,022  Opioid kappa receptor agonist
0,069  0,039  HIV-1 integrase (3'-Processing) inhibitor
0,045  0,016  Cholesterol absorption inhibitor
0,084  0,056  D-Ala-D-Ala ligase inhibitor
0,050  0,024  Estradiol 17 beta-dehydrogenase inhibitor
0,088  0,063  Actinic keratosis treatment
0,044  0,019  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,113  0,088  Cyclooxygenase 2 inhibitor
0,090  0,065  HIV-1 integrase (Overall Integration) inhibitor
0,096  0,072  Urease inhibitor
0,043  0,020  Kinesin antagonist
0,043  0,020  Kinesin-like protein 1 inhibitor
0,058  0,035  Protein kinase C eta inhibitor
0,116  0,095  Antifungal enhancer
0,157  0,137  Antineoplastic (lymphocytic leukemia)
0,062  0,046  Glucagon-like peptide 1 agonist
0,071  0,055  Antibiotic
0,029  0,014  Sodium/glucose cotransporter 2 inhibitor
0,072  0,058  Analgesic, opioid
0,142  0,128  Angiogenesis stimulant
0,028  0,014  Sodium/glucose cotransporter inhibitor
0,073  0,060  Antitreponemal
0,089  0,076  Alpha 2c adrenoreceptor antagonist
0,073  0,061  Macrophage migration inhibitory factor inhibitor
0,210  0,197  Antiobesity
0,111  0,099  Interleukin 4 antagonist
0,168  0,156  Radioprotector
0,037  0,026  Glucose-6-phosphate dehydrogenase inhibitor
0,069  0,059  Carbonic anhydrase XIII inhibitor
0,060  0,054  Neuraminidase (influenza) inhibitor
0,135  0,130  Lipocortins synthesis antagonist
0,116  0,111  Antidote
0,043  0,038  Antibiotic Glycopeptide-like
0,015  0,011  NMDA receptor phencyclidine site antagonist
0,051  0,049  HIV-1 integrase (Strand Transfer) inhibitor
0,201  0,198  FMO1 substrate
0,087  0,085  Expectorant
0,144  0,141  Dependence treatment
0,129  0,127  Heat shock protein 70 antagonist
0,022  0,021  Sodium/glucose cotransporter 1 inhibitor
0,028  0,028  Nucleoside transporters inhibitor

